America first, others may die: U.S. buys almost all supply of remdesivirChristian Fernsby ▼ | July 1, 2020
The United States is undermining the global effort to fight the coronavirus pandemic by buying up virtually the whole supply of a drug that could shorten the recovery time of patients, leaving hardly any for other countries.
Topics: U.S. remdesivir
He added: "By attempting to compete we ultimately undermine all our strategies."
Remdesivir, an antiviral drug, is made by biopharmaceutical company Gilead Sciences, based in California. America has secured more than 500,000 treatment courses through September.
That represents 100 percent of Gilead’s projected production for July, and 90 percent for each of the next two months. ■